Achieve Life Sciences (ACHV) Accumulated Depreciation (2012 - 2020)
Achieve Life Sciences (ACHV) posted Accumulated Depreciation of $632000.0 for Q4 2020, up 5.33% on a QoQ basis from $600000.0 in Q4 2019, and up 5.33% year-over-year from $600000.0 in Q1 2020.
Achieve Life Sciences (ACHV) Accumulated Depreciation (2012 - 2020) Analysis & Trends
Achieve Life Sciences' Accumulated Depreciation history runs 9 years deep, the most recent figure standing at $632000.0 for Q4 2020.
- Quarterly Accumulated Depreciation rose 5.33% year-over-year to $632000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $632000.0 (up 5.33% YoY) and the FY2020 annual result came in at $632000.0, up 5.33% from the prior year.
- Accumulated Depreciation was $632000.0 for Q4 2020 at Achieve Life Sciences, up from $600000.0 in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $1.4 million in Q4 2016 and bottomed at $600000.0 in Q4 2019.
- A 5-year average of $897200.0 and a median of $720000.0 in 2018 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2016 — Accumulated Depreciation gained 13.11% — and 2018, when it sank 33.64%.
- Achieve Life Sciences' Accumulated Depreciation stood at $1.4 million in 2016, then slipped by 25.12% to $1.1 million in 2017, then sank by 33.64% to $720000.0 in 2018, then decreased by 16.67% to $600000.0 in 2019, then gained by 5.33% to $632000.0 in 2020.
- Business Quant data shows ACHV's Accumulated Depreciation at $632000.0 in Q4 2020, $600000.0 in Q4 2019, and $720000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 632,000.00 |
| Dec 31, 2019 | 600,000.00 |
| Dec 31, 2018 | 720,000.00 |
| Dec 31, 2017 | 1.09 Mn |
| Dec 31, 2016 | 1.45 Mn |
| Dec 31, 2015 | 1.28 Mn |
| Dec 31, 2014 | 1.04 Mn |
| Dec 31, 2013 | 814,000.00 |
| Dec 31, 2012 | 604,000.00 |